Category Archives: Science & Technology

WORLD RECORDS : INDIA PATENTS : HumCen Global Backed World Record For 100 Patent Filings in 24 Hours!

HumCen Global (P) Ltd has successfully organised a huge event on World IP Day, April 26, 2022, with the primary goal of filing 100 Indian Design patents in 24 hours. The World Book of Records (LONDON) recognized and commended this bold initiative.

The team from HumCen Global Pvt Ltd and Trichy’s K Ramakrishnan College of Technology worked tirelessly to attain this goal. As a result, the “100 Design Patent Filed within 24 hours”, this claim was a first-of-its-kind effort around the globe.

The crew works bright filing the first patent at 2:42 AM,. It was not easy, but sheer determination got the team through, and the record-breaking patent was achieved at 11:32 p.m.

As a strategic patent consulting partner of K Ramakrishnan College of Technology (Autonomous) in Trichy, Tamil Nadu, India, it was an excellent overall experience for HumCen Global Pvt Ltd in Chennai, TamilNadu, India to work for the theme IP and Youth: Innovating for a Better Future with 300+ Student Innovators cum Faculties.

globenewswire.com

GLOBAL RECORDS: INDIA RECORDS: India-born Scientist & Conservation Biologist Kamal Bawa Elected to US National Academy of Sciences

Conservation biologist Kamal Bawa has been elected to the U.S. National Academy of Sciences. Kamal Bawa is president of the Bengaluru-based Ashoka Trust for Research in Ecology and Environment (ATREE) as well as an elected fellow of the Royal Society (London) and the American Philosophical Society.

“The election is a reaffirmation of our important work on the ecology, conservation, and management of tropical forests that are declining all over the world but are critical to humanity’s well-being,” said Dr. Bawa.

A few years ago, Dr. Bawa brought together scientists from India’s leading institutions to develop the National Mission on Biodiversity and Human Wellbeing under the banner of the Biodiversity Collaborative.

The effort was supported by the office of the Principal Scientific Adviser to the Government of India, and is currently funded by the Rohini Nilekani Philanthropies.

source/content: thehindu.com (edited)

INDIA RECORDS : SCIENCE & TECHNOLOGY : MEDICENE : First Surgery of Budd-Chiari Syndrome, a serious condition of Liver Disorder done by IMS-BHU Doctors

For the first time a team of doctors from the Institute of Medical Science, Banaras Hindu University (IMS-BHU) performed a surgical procedure to cure a patient suffering from Budd-Chiari Syndrome, a serious condition of the liver.

The doctors from the interventional radiology unit of the department of radio diagnosis and imaging performed the surgery.

The syndrome is a medical condition in which the hepatic veins (veins that drain the liver) are blocked or narrowed by a clot (mass of blood cells). This blockage causes blood to back up into the liver, and as a result, the liver grows larger.

Prof. Ashish Verma, head of the department of radiodiagnosis and imaging, who led the team, said, “It is for the first time that the trans-jugular intrahepatic Porto systemic shunt procedure has been done on a patient. The procedure has been performed on a young woman suffering from a condition called the Budd-Chiari Syndrome.”

source/content: daijiworld.com (edited)

INDIA RECORDS : 2 PATENTS : Arunachal Scientist Dr. Sanjeeb Kalita Bags Two Indian Patents for Diabetes Treatments

Dr. Sanjeeb Kalita has been granted two Indian patents for developing ‘Polyherbal formulation for the treatment of painful ‘Diabetic Neuropathy’ and ‘hybrid cotton patch’ and a method for its fabrication.

A scientist from the Centre of Excellence (CoE) for Bio-resources and Sustainable Development at Kimin in Papumpare district of Arunachal Pradesh has been granted two Indian patents for developing ‘Polyherbal formulation for the treatment of painful Diabetic Neuropathy’ and ‘hybrid cotton patch and a method for its fabrication’.

Dr. Sanjeeb Kalita, the scientist of the centre under the Arunachal Pradesh State Council for Science and Technology (APSCS&T) carried out fundamental research and development for both the inventions at Guwahati-based Institute of Advanced Studies in Science and Technology, official sources said on Friday.

source/content: thehindu.com (edited)

INDIA RECORDS : PATENT FOR PHARMACEUTICALS : CET Obtains Patent for Compound with Anti-Cancer Properties

The compound has been derived from the medicinal plant Koduveli.

The College of Engineering Thiruvananthapuram (CET) has bagged a patent for inventing a pharmaceutical agent that is expected to have immense potential in cancer treatment.

The newly synthesised compound, 3-([4-Chloro-3(Trifluoromethyl) Phenyl] Amino)-5-Hydroxy-2-Methyl-1,4-Dihydronapthalene-1,4-Dione, was the result of the five-year long research jointly undertaken by Shyni P. Laila and Arunkumar B.

The researchers were guided by Annette Fernandez, the former head of the Department of Chemistry at CET who had retired as Principal of the Government College of Arts and Science, Pathirippala, in Palakkad few years ago.

They pointed out the pharmaceutical agent is a fluoro derivative (a derivate compound obtained by reaction with a fluoro-compound) which was derived by structural modification of a hydroxyquinone, Plumbagin, that was isolated from the roots of Plumbago zeylanica, a medicinal plant known as Koduveli in local parlance.

source/content: thehindu.com (edited)

GLOBAL CONTRACTS – INDIA TO THE WORLD: ASIA : MEDICINE & SCIENCE : Biocon Biologics Bags $90-mn Contract from Malaysian Government to Supply Human Insulin

Biocon Biologics Insugen formulations will be available to all Ministry of Health hospitals, district health offices, and health clinics.

Biocon Biologics Limited (BBL), a subsidiary of Biocon on Tuesday said it has bagged a three-year contract valued at $90 million from the Malaysian government for the supply of recombinant human insulin brand Insugen.

Biocon Sdn Bhd., a subsidiary of Biocon Biologics, will manufacture and supply its range of insulins to its partner Duopharma Marketing Sdn. Bhd. (DMktg), a subsidiary of Duopharma Biotech, a pharma & biotech firm in Malaysia.

Biocon Biologics’ Insugen formulations will be available to patients at all Ministry of Health hospitals, district health offices, and health clinics, as per an official statement.

 

source/content: thehindu.com (edited)

GLOBAL LEADER : EUROPE : Scotland’s Indian-Origin COVID Adviser Professor Dr. Devi Sridhar, Edinburgh University Reveals Face Mask Threat

Devi Sridhar, professor of global public health at Edinburgh University who is on the Scottish government’s coronavirus advisory board, told ‘The Times’ newspaper this weekend that she was sent white powder and a used face mask in the post last year.

“I was extremely shaken and it was probably the hardest part because it was in my real life, not virtual or online,” said Sridhar, who often appears on UK radio and television as an expert commentator on the COVID-19 pandemic.

source/content: economictimes.indiatimes.com (edited)

GLOBAL EXCELLENCE : UAE RECORDS : Indian Doctor Dr Zainul Aabideen Performs 1st Pediatric Stem Cell Transplant in UAE

A Indian Malayali doctor in Abu Dhabi wrote himself into record books when he performed the first pediatric stem cell bone marrow transplant in the UAE.

Dr Zainul Aabideen, a native of Kannur in Kerala, presently Head of the Department of Pediatric Hematology and Oncology at Burjeel Medical City successfully performed the advanced allogeneic procedure on a five-year-old girl from Uganda with sickle cell disease.

Billed as the first such surgery done in the UAE, the patient’s 10-year-old sister donated her bone marrow for the transplant treatment at Burjeel Medical City, a flagship hospital of VPS Healthcare.

Sickle cell disease is a genetic disorder, which results in an abnormality in the hemoglobin found in red blood cells, causing them to become sickle-shaped and leading to several complications including anemia, swelling in the hands and feet, frequent pain, acute chest syndrome, and sometimes stroke.

Prior to the treatment, the child has been regularly admitted to the hospital due to complications arising from her disease since birth.

source/content: awazthevoice.in (edited)

PATENT: INDIAN INNOVATION : SCIENCE & TECHNOLOGY : Allahabad University Students Develop Device to Check Backflow after Injection

The students of the chemistry department in Allahabad University (AU), led by their supervisor and dean faculty of science Prof Shekhar Srivastava, have developed a device which will prevent backflow of injected liquid in humans.

The device will automatically lock the output pipe after the stipulated amount of medicine or for that matter any liquid as being injected by the doctor has been injected in the body.

The device has been granted patent for a period of 10 years by the Kolkata-based office of General of Patent, Design and Trademark, ministry of Commerce and Industry, Government of India.

The device is the effort of a team led by Prof Srivastava and included research scholars Rahul Kannaujia, Ghulam Mustafa and Mukta Singh.

source/content: daijiworld.com (edited)

INDIAN INNOVATION – GREEN : SCIENCE & TECHNOLOGY : IIT Guwahati Develops Technology to Standardise Electric Vehicles in India

Indian Institute of Technology (IIT) Guwahati has developed a technology that rates the motors and batteries of electric vehicles and suggests the best drivetrain components for the Indian scenario to Original Equipment Manufacturers (OEMs).

According to IIT Guwahati, this is a unique method of its kind which standardises the electronic vehicles based on Indian drive-cycles.

T. G. Sitharam, director, IIT Guwahati, said, “The development in the field of next-generation energy-efficient EV technology is one of the most important breakthroughs required for the sustainable development of the country and to reduce the carbon footprint. IIT Guwahati is earnestly working in this direction. This development will augment this process and maximize the outcomes.”

source/content: thetelegraph.com (edited)